Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Renaissance Lakewood, LLC Plans US$40 million Expansion in New Jersey
Renaissance Lakewood, LLC opens new main campus footprint in Ocean County, NJ The new campus will focus on the future growth of topof theline nasal and injectable products
Jaguar Gene Therapy Plans US$125 million Investment
Jaguar Gene Therapy plans to open new commericial manufacturing facility in North Carolina It expands stargegic capabilities from process development through commercial GMP production
Stevanato Group Invests US$145 million in Construction of New Facility in North America
Stevanato Group plans to open new manufacuting facility in North America The new facility will provide an additional supply source for its mission critical products
FUJIFILM Diosynth Biotechnologies Opens New Biopharmaceutical CDMO Facility In North America
FUJIFILM Diosynth Biotechnologies plans for the construction of largest cell culture biophramaceutical CDMO facility The facility will be located in North America
Boehringer Ingelheim Invests US$794 million (€700 million) in Austria
Boehringer Ingelheim palns for the construction of new biopharmaceutical production capacity The new facility will be located in Austria
Clean Cells Invests US$14.7 (€13) million to Open New Biopharmaceutical Production Site
Clean Cells with an investment of US$147 million 13 million plans to open new production site located in MontaiguVende
Umoja Biopharma Opens New Manufacturing Facility in Louisville, Colorado, US
Umoja Biopharma, plans for the construction of new manufacturing facility The new facility will be dedicated for the production of nextgeneration CAR T immunotherapies The stateoftheart facility designed with 146,000 square foot will overcome the production barriers and delivers effective
Nkarta Constructs New NK Cell Therapy Manufacturing Facility in South San Francisco
Nkarta, Inc plans to construct new manufacturing facility The facility will be home for companys headquarters including administrative offices and laboratories for research development activities The facility covering an area of 88,000 square foot facility will be used for supporting research
Artiva Biotherapeutics to Construct New Research and Manufacturing Center in Republic of Korea
Artiva Biotherapeutics plans to construct new GMP manufacturing center The facility will be an addition to the Artivas continued research and GMP manufacturing at its partner GC LabCells center The new facility designed with 52,000squarefoot will support to develop and provide safe and effective cancer therapies
Yposkesi Plans to Construct Second Bioproduction Site in Europe
Yposkesi plans to open new bioproduction site with an investment of US$71 million 58M The site features two additional production lines with numerous 1000L scale bioreactors In addition, it also includes quality control lab resources, centralized warehouse
